NCT00711477View on ClinicalTrials.gov

A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Obesity
Interventions
DRUG

Naltrexone SR 32 mg/bupropion SR 360 mg/day

DRUG

Placebo

OTHER

fMRI scan

fMRI to assess the effects of the drug/placebo on areas of the brain

Trial Locations (1)

11973

Brookhaven National Laboratory Medical Department, Upton

Sponsors
All Listed Sponsors
lead

Orexigen Therapeutics, Inc

INDUSTRY